About the Journal

Focus and Scope

The Journal of Medicines Development Sciences focuses on the discovery and development of new medicinal products. The journal publishes original research articles on medicinal chemistry, experimental pharmacology including pharmacokinetics, preclinical safety, clinical pharmacology, pharmacogenomics, clinical research, pharmacoepidemiology and pharmacoeconomics. The journal also publishes brief reports on new research findings and review articles. Articles encouraging taking the therapy from bench to bedside and creating a broad readership of young researchers, clinicians and scientists are welcome.

Peer Review Process

All manuscripts submitted to this journal will follow the following procedure:

• Initial submission are reviewed by in-house editors to ensure adherence to journal policies and for double-blind review
• Editor-in-chief decides on the manuscript to be sent out for review process and assigns the manuscript to one of the editors according to the particular topic.
• Editor assigns reviewers from inside the editorial board or outside depending on the topic.
• After evaluations by the reviewers have been received, the editor-in-chief makes one of the following recommendations: accept, minor revision, major revision, reject and resubmit, and reject.
• If decision is minor revision, the authors have 7 days to resubmit the revised manuscript.
• If decision is major revision, the authors have 14 days to resubmit the revised manuscript.
• Upon resubmission, the same procedure is applied as for the initial submission.
• Authors may appeal for a rejected submission. Appeal requests must be made in writing to editorial@whioce.com with detailed reasons for the appeal and point by point responses to the reviewers remarks. Decisions on appeals are final without exception.
• For all manuscripts accepted for publication, the peer review process will be deemed to be completed. The manuscript will proceed to be copyedited, layout edited and proofread before being published online.

Note: You may suggest up to four academically qualified reviewers for consideration. Please insert the current contact details of the reviewer and state the reason(s) for recommendation under the "Comments for the Editor" section. However, please take note that the Editorial team strives to ensure the peer review process is fair and unbiased and hence, there is no guarantee that a recommended reviewer will be approached to perform the peer review.

Publication Frequency

Yearly

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Editor-in-Chief

Boeynaems, Jean-Marie

Editorial Board

For the list of editorial board members, click here.

Authorship

Authorship should be limited to people who have contributed substantially to the work. Authors must indicate their specific contributions to the published work. This information should be listed in the manuscript under the section ‘Author Contribution’. Examples of contributions include: designed research, performed research, contributed new reagents or analytic tools, analyzed data, wrote the paper.

For more information on submission’s format, please refer to the ‘Author Guidelines’ link accessible from the ‘About’ button at the top row of this page.

The corresponding author should be clearly indicated for all manuscripts submitted. A maximum of two corresponding authors are allowed for the responsibilities associated. The corresponding author(s) is responsible for:

• Obtaining permission from all the authors mentioned in the manuscript
• Ensuring adherence to all editorial and submission policies and for any communications and actions that may be necessary after publication
• Including written permission from the authors of the work concerned for any mention of any unpublished material included in the manuscript, e.g. data from manuscripts-in-press, personal communication, or work in preparation. 

Conflict of Interest

The author has to provide the authorization of no conflict with any financial body or funding agency that might influence the results or interpretation of their manuscript. All authors, members, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. The corresponding author will be asked to sign a form behalf of all of the authors regarding potential conflicts of interest at the time of acceptance.

Plagiarism

The editorial team does not approve of any plagiarism attempts. iThenticate will be utilized at the editor’s discretion to verify the originality of submitted manuscripts. If plagiarism is detected during the review process the manuscript may be rejected pending the severity of plagiarism. Therefore, if a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited.

Language

All articles must be written in English — preferably American English. SI units should be used. If you are not a native English speaker, you may want to utilize an external or Whioce Publishing’s optional professional language editing service before submitting the final version.

Whioce Publishing Pte Ltd offers its own professional editing services. By using this service, you can be sure that your English-language manuscript will be polished and ready for submission to your publication of choice at a very reasonable price. For further details about the Language Editing Services, please contact us at academic@whioce.com. Please note that utilizing a language editing service is not a guarantee of acceptance.

Advertising Policy

All advertisements are subject to approval to the Publisher. Advertisements must comply with the relevant regulations in the country where the advertisements appears. For more inquiries, please send email to editorial@whioce.com.

Data Processing Policy

Authors are expected to have minimum amount of post-acquisition processing of data. In case of processing; alterations must be applied to the entire image (e.g., brightness, contrast, color balance). Any kind of alteration if being done has to be clearly stated in the figure legend and in Methods section.

Grouping of data (e.g., cropping of images of removal of lanes from gels and bolts) must be made apparent and should be explicitly indicated in the appropriate figure legends. Data comparisons should only be made from comparative experiments, and individual data should not be utilized across multiple figures. If inappropriate image/data manipulation is identified after publication, we reserve the right to ask for the original data and, if that is not satisfactory, to issue a correction or retract the paper, as appropriate.

Indexing and Archiving

Journal of Medicines Development Sciences (JMDS) aims to be indexed by world-recognized databases, for example, PubMed, Scopus and Science Citation Index (SCI). JMDS has been indexed and archived by several databases:

• CNKI Scholar (中国知网)
• Crossref
• Google Scholar
• JournalTOCs
• National Library Board of Singapore
• Portico
• Scilit
• Worldcat

Editorial Policies

A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. The author will need to notify the editorial team if the data in their submission has been presented in conferences.

After acceptance, the Publisher will have the right to edit the work for the original edition and for any revision.

Code of Ethics and Practices

WHIOCE Publishing requests all members involved in the journal publishing process to adhere the Core Practices on publication ethics as stipulated by COPE (Committee on Publication Ethics). The guidelines define the best practice in the ethics of scholarly publishing, aiding the journals and publishers to achieve this.